ScholarIQanswers from OpenAlex

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target

PaperCitations, authors & open-access status

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target is a paper indexed in ScholarIQ from OpenAlex.

How many citations does PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target have?

ScholarIQcitation count

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target has 126 citations in the OpenAlex counts ScholarIQ stores.

When was PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target published?

ScholarIQyear

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target has 2011 year in the ScholarIQ index.

What is the open-access status of PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target?

ScholarIQoa status

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target has closed oa status in the ScholarIQ index.

What is the DOI of PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target?

ScholarIQdoi

The DOI for PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target is on the source record.

What is the PMID of PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target?

ScholarIQpmid

The PMID for PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target is on the source record.

What is the OpenAlex record for PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target?

ScholarIQopenalex

The OpenAlex for PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial